![]() |
市场调查报告书
商品编码
1383420
2030 年剂量监测市场预测:按产品类型、应用、最终用户和地区分類的全球分析Dose Monitoring Market Forecasts to 2030 - Global Analysis By Product Type (Hardware, Software and Services ), Application (Radiography, Radiotherapy and Other Applications), End User and By Geography |
根据Stratistics MRC预测,2023年全球剂量监测市场规模将达到43.6亿美元,预计2030年将达到79.7亿美元,预测期内年复合成长率为9.0%。
在各种医疗保健环境中检测、追踪和控制输送给患者的辐射量和药物的过程称为剂量监测。确保患者安全、最佳化治疗结果、遵守法规标准都取决于剂量监测。剂量监测是指准确检测和追踪诊所、医院和其他医疗机构对病人给药的药物量。它不仅可以确保患者给药正确的剂量,还有助于防止用药错误并追踪药物剂量,以确保患者的安全和依从性。
影像技术的开拓是剂量监测市场扩大的主要因素。由于这些技术进步,医疗诊断和治疗计划领域正在经历重大变革。 电脑断层扫描、MRI 扫描和 PET 扫描等先进显像模式可提供更好的影像品质和诊断准确性,在现代医疗保健中变得越来越重要。然而,其中许多技术,尤其是多层 CT 扫描仪和介入放射学程序,使患者暴露在高剂量的电离辐射下。因此,迫切需要准确的剂量监测以确保病人安全。剂量监测解决方案对于追踪和给药这些先进影像处理中的辐射剂量至关重要。
实施剂量监测技术成本高。这包括购买、配置和认证必要的设备和应用程式的成本,以及培训医务人员如何有效使用该技术的成本。然而,一些医疗机构,特别是预算有限的小型机构,可能会因为初期成本高昂而犹豫是否实施这些解决方案。因此,高昂的初始成本是市场扩张的主要障碍。
给药监测有多种可能性,因为先进的资料分析提供了灵活的方法来提高病人安全、治疗效果和业务效率。资料分析可能是彻底改变剂量监测应用和利用的关键因素,特别是在法规和医疗保健提供者继续强调辐射安全的重要性的情况下。这些系统可撷取放射治疗和诊断成像期间辐射暴露的详细资料。使用高级资料分析对这些资料进行处理和分析,以提供富有洞察力的结论。这些东西正在增加市场需求。
剂量监测市场非常难以改变。这主要是由于在医疗保健环境中实施新程序和技术时遇到的困难。剂量监测的整合有可能脱离医疗保健工作者和机构经常遵循的既定工作流程。如果某些放射肿瘤科和医学部门担心变革会影响其日常业务,他们可能会抵制变革。此外,抗药性可能与建立和维护剂量监测计划的困难有关。当新技术被引入时,员工需要接受特殊培训,这在过渡时期可能会很费力。
此次疫情增加了对医学影像的需求,特别是用于监测和诊断 COVID-19 病例的 CT 和胸部 X 光检查。诊断影像服务需求的增加直接影响了对剂量监测解决方案的需求,以确保患者接受适当的剂量,同时最大限度地减少不必要的暴露。疫情推动了剂量监测软体等数位健康技术的采用。随着医疗保健提供者寻求远端患者资料管理和监测解决方案,数位剂量监测工具的价值不断增加。
预计软体产业将占据最大份额。剂量监测软体是指旨在追踪、管理和分析给药患者的辐射和药物剂量的专用程序和应用程式。该软体对于确保准确的剂量管理、降低风险和改善患者治疗效果至关重要。它帮助医学物理学家和放射肿瘤学家优化治疗方法,确保成功靶向肿瘤,同时最大限度地减少对附近健康组织的伤害。该软体的即时监测和调整功能使放射治疗更加准确。
诊断中心部门预计在预测期内将出现良好的成长。剂量监测系统透过将辐射暴露限制在安全水平来帮助医疗保健专业人员降低患者健康风险。剂量监测解决方案透过确保按照建议的剂量水平和安全程序进行诊断成像,有助于遵守这些法规。透过简化资料收集和报告流程,剂量监测软体可以提高诊断中心的效率。它不仅确保辐射安全,而且还使医务人员能够腾出时间专注于病患照护。
在估计期间,北美占据了最大的市场占有率。剂量监测市场的主要参与者是美国和加拿大。该地区拥有强大的医疗保健系统和尖端医疗技术的高采用率。北美医疗保健组织和提供者是实施尖端医疗技术的先驱。剂量监测在该领域非常重要,无论是对于医院的药物给药还是对于癌症治疗中使用的放射治疗。随着法规的收紧和技术的进步,该地区将继续成为支持全球剂量监测产业的主要力量。
由于其先进的医疗基础设施和严格的法规环境,预计欧洲在预测期内将实现盈利增长。由于欧洲医疗保健配合措施提供高品质的患者照护,因此剂量监测解决方案的需求量很大。更严格的立法和对病人安全的重视鼓励使用最尖端科技进行剂量监测。德国是欧洲经济强国之一,拥有发达的医疗设施和完善的医疗保健体系。
According to Stratistics MRC, the Global Dose Monitoring Market is accounted for $4.36 billion in 2023 and is expected to reach $7.97 billion by 2030 growing at a CAGR of 9.0% during the forecast period. The process of measuring, tracking, and controlling the amount of radiation or medication given to patients in different healthcare settings is known as dose monitoring. Ensuring patient safety, optimizing treatment outcomes, and adhering to regulatory standards all depend on it. The precise measurement and tracking of drug doses administered to patients in clinics, hospitals, or other healthcare facilities is referred to as dose monitoring. In addition to guaranteeing that patients receive the right doses, this also helps to prevent medication errors and keeps track of medication administration for patient safety and compliance.
Developments in imaging technology are a major factor in the market expansion for dose monitoring. The field of medical diagnosis and treatment planning has seen a substantial transformation as a result of these technological advancements. Advanced imaging modalities like CT, MRI, and PET scans, which provide better image quality and diagnostic accuracy, are becoming increasingly important in modern healthcare. However, a lot of these techniques expose patients to higher doses of ionizing radiation, especially multi-slice CT scanners and interventional radiology procedures. Therefore, accurate dose monitoring is urgently required to guarantee patient safety. In order to track and manage the radiation doses administered during these advanced imaging procedures, dose monitoring solutions have become essential.
Dose-monitoring technology implementation can be costly. This covers the cost of purchasing, setting up, and certifying the required gear and applications, in addition to the cost of educating medical staff on how to use the technology efficiently. However, some healthcare facilities, especially smaller ones with tighter budgets, may be discouraged from implementing these solutions due to the substantial upfront costs. Therefore, high initial cost is a significant barrier to market expansion.
Dose monitoring has a lot of potential because advanced data analytics offer a flexible way to improve patient safety, treatment efficacy, and operational efficiency. Data analytics can be a key factor in revolutionizing the application and utilization of dose monitoring, particularly as regulators and healthcare providers continue to stress the significance of radiation safety. These systems capture minute details regarding radiation exposure during radiation therapy and diagnostic imaging. This data can be processed and analyzed using advanced data analytics to provide insightful conclusions. These factors enhance market demand.
The market for dose monitoring is highly resistant to change, which is mostly caused by the difficulties that come with introducing new procedures and technology in healthcare settings. Integrating dose monitoring may break out of the well-established workflows that healthcare practitioners and institutions frequently follow. Particular departments dealing with radiation oncology and radiology may be resistant to change if they worry it will affect their daily operations. Furthermore, resistance may be associated with worries about how difficult it will be to set up and maintain dose monitoring programs. Staff may need extra training when new technologies are introduced, and this transitional period may be burdensome.
Due to the pandemic, there was an increase in the need for medical imaging, particularly CT and chest X-rays, which were necessary for COVID-19 case monitoring and diagnosis. The need for dose monitoring solutions to make sure that patients received the right radiation doses while minimizing unnecessary exposure was directly impacted by the rise in demand for imaging services. The adoption of digital health technologies, such as dose monitoring software, was expedited by the pandemic. The increased value of digital dose monitoring tools was driven by healthcare providers' desire for remote patient data management and monitoring solutions.
The software segment is estimated to hold the largest share. Dose monitoring software refers to the specialized programs and applications designed to track, manage, and analyze radiation or medication doses administered to patients. This software is essential for guaranteeing accurate dosage administration, reducing hazards, and improving patient outcomes. It assists medical physicists and radiation oncologists in optimizing treatment regimens, guaranteeing that the tumor is successfully targeted while causing the least amount of harm to nearby healthy tissues. Radiation therapy is more accurate due to the software's real-time monitoring and adjustment features.
The diagnostic centers segment is anticipated to have lucrative growth during the forecast period. By restricting radiation exposure to safe levels, dose monitoring systems assist medical professionals in reducing the risk to their patients' health. By guaranteeing that the diagnostic imaging procedure is carried out in compliance with the advised dose levels and safety procedures, dose monitoring solutions help to ensure compliance with these regulations. Through the simplification of the data collection and reporting process, dose monitoring software can increase the effectiveness of diagnostic centers. In addition to guaranteeing radiation safety, this allows medical staff to concentrate on patient care.
North America commanded the largest market share during the extrapolated period. The key players in the dose monitoring market are the US and Canada. The region has a strong healthcare system and a high rate of uptake of cutting-edge medical technology. Healthcare organizations and providers in North America are pioneers in the adoption of state-of-the art medical technologies. In this area, dose monitoring is critical for both medication dosing in hospitals and radiation therapy used in cancer treatment. This region will continue to be a major force behind the global dose monitoring industry as regulations tighten and technology advances.
Europe is expected to witness profitable growth over the projection period, owing to its advanced healthcare infrastructure and rigorous regulatory environment. The demand for dose monitoring solutions is high because of the dedication to high-quality patient care that characterizes the European healthcare landscape. The use of cutting-edge technologies for dose monitoring has been fuelled by stricter laws and a focus on patient safety. Germany, one of the economic superpowers of Europe, boasts highly advanced medical facilities and a well-developed healthcare system.
Some of the key players in the Dose Monitoring Market include: GE Healthcare, Siemens Healthineers, Bayer AG, Mirion Technologies, Philips Healthcare, Varian Medical Systems, Sectra AB, Civco Medical Solutions, Nelco Worldwide and Medsquare.
In July 2023, Bayer and Peking University (PKU) collaborated to foster the translation of basic pharmaceutical research into drug discovery and development, while accelerating scientific research on cutting-edge technologies across the pharmaceutical value chain.
In February 2022, Siemens Healthineers and UNICEF partner to help improve access to healthcare in sub-Saharan Africa. The partnership will help optimize Point-of-Care (POC) diagnostics networks, strengthen health systems strained by the protracted pandemic and foster community engagement.